Literature DB >> 27494672

Current Public Support for Human-Animal Chimera Research in Japan Is Limited, Despite High Levels of Scientific Approval.

Yusuke Inoue1, Ryuma Shineha2, Yoshimi Yashiro3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27494672     DOI： 10.1016/j.stem.2016.07.011

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


× No keyword cloud information.
  6 in total

1.  The Japanese Generally Accept Human-Animal Chimeric Embryo Research but Are Concerned About Human Cells Contributing to Brain and Gametes.

Authors:  Tsutomu Sawai; Taichi Hatta; Misao Fujita
Journal:  Stem Cells Transl Med       Date:  2017-07-11       Impact factor: 6.940

Review 2.  Induced pluripotent stem cell technology: a decade of progress.

Authors:  Yanhong Shi; Haruhisa Inoue; Joseph C Wu; Shinya Yamanaka
Journal:  Nat Rev Drug Discov       Date:  2016-12-16       Impact factor: 84.694

3.  A comparative analysis of attitudes toward stem cell research and regenerative medicine between six countries - A pilot study.

Authors:  Ryuma Shineha; Yusuke Inoue; Yoshimi Yashiro
Journal:  Regen Ther       Date:  2022-05-13       Impact factor: 3.651

4.  Public Support in the U.S. for Human-Animal Chimera Research: Results of a Representative Cross-Sectional Survey of 1,058 Adults.

Authors:  Jonathan Kantor
Journal:  Stem Cells Transl Med       Date:  2017-04-21       Impact factor: 6.940

5.  A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community.

Authors:  Ryuma Shineha; Yusuke Inoue; Tsunakuni Ikka; Atsuo Kishimoto; Yoshimi Yashiro
Journal:  Stem Cells Transl Med       Date:  2018-01-26       Impact factor: 6.940

6.  Science communication in regenerative medicine: Implications for the role of academic society and science policy.

Authors:  Ryuma Shineha; Yusuke Inoue; Tsunakuni Ikka; Atsuo Kishimoto; Yoshimi Yashiro
Journal:  Regen Ther       Date:  2017-12-06       Impact factor: 3.419
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.